Montelukast Warning Upgraded

]]>(MedPage Today) -- WASHINGTON--Concerned about "continued reports of suicide" and other neuropsychiatric events among users of the allergy and asthma drug montelukast (Singulair), the FDA is moving previous warnings about these risks into a...